Total planned funding: $491,356,646
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $79,942,780 |
Nigeria | $62,608,267 |
Zambia | $53,648,466 |
South Africa | $47,901,791 |
Zimbabwe | $33,812,624 |
Asia Regional Program | $28,271,438 |
Tanzania | $21,134,919 |
West Africa Region | $18,148,918 |
Burundi | $14,196,544 |
Vietnam | $13,890,027 |
Botswana | $12,324,286 |
India | $11,864,357 |
Haiti | $10,464,552 |
Côte d'Ivoire | $10,459,567 |
Kenya | $8,872,190 |
Democratic Republic of the Congo | $8,324,485 |
Malawi | $7,879,705 |
Indonesia | $7,051,794 |
Ghana | $6,982,500 |
Dominican Republic | $5,848,850 |
Eswatini | $4,638,942 |
South Sudan | $3,435,929 |
Rwanda | $2,594,238 |
Caribbean Region | $2,525,420 |
Papua New Guinea | $2,486,306 |
Angola | $2,466,719 |
Ethiopia | $2,324,111 |
Cambodia | $2,025,000 |
Uganda | $1,795,686 |
Lesotho | $1,638,960 |
Namibia | $1,497,275 |
enumerations.Philippines | $300,000 |
Central Asia Region | $0 |
Organizational Types
NGO | $491,356,646 |
Program Areas
Treatment | $138,608,808 |
Prevention | $129,636,361 |
Care | $122,237,193 |
Testing | $54,610,074 |
Governance and Systems | $46,101,916 |
Management and Operations | $162,294 |
Budget Codes
HTXS: Treatment: Adult Treatment | $124,650,697 |
HVOP: Sexual Prevention: Other Sexual Prevention | $86,946,386 |
HKID: Care: Orphans and Vulnerable Children | $66,936,331 |
HVCT: Testing: HIV Testing and Counseling | $54,610,074 |
HBHC: Care: Adult Care and Support | $36,502,359 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $19,621,818 |
OHSS: Health Systems Strengthening | $18,508,429 |
HVSI: Strategic Information | $15,166,574 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $14,010,443 |
PDTX: Treatment: Pediatric Treatment | $13,958,111 |
HLAB: Laboratory Infrastructure | $12,426,913 |
PDCS: Care: Pediatric Care and Support | $9,901,767 |
HVTB: Care: TB/HIV | $8,896,736 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $4,403,186 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $3,930,415 |
HMBL: Biomedical Prevention: Blood Safety | $391,329 |
HMIN: Biomedical Prevention: Injection Safety | $332,784 |
HVMS: Management and Operations | $162,294 |
HTXD: Treatment: ARV Drugs | $0 |
Top Partner Programs
FHI 360:
$491,356,646
View countries